Alvotech acquires Xbrane’s R&D operations in Sweden and biosimilar candidate XB003
Thursday announced the acquisition of Xbrane Biopharma AB’s R&D operations and a biosimilar candidate, establishing a footprint in the Swedish life science sector. The acquisition’s purchase price ...
The Bakersfield Californian10d
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today ...
Icelandic Biotech Company Alvotech to Explore Listing in Stockholm
Icelandic biotechnology company Alvotech intends to explore the possibility of a Stockholm listing as it announced the acquisition of a Swedish research and development operation and drug candidate.